TY  - JOUR

T1  - M‐EA
            (methotrexate, etoposide, dactinomycin) and
            EMA‐CO
            (methotrexate, etoposide, dactinomycin / cyclophosphamide, vincristine) regimens as first line treatment of high‐risk Gestational Trophoblastic Neoplasia

JO  - International Journal of Cancer

PY  - 2020/11/19

AU  - Singh K

AU  - Gillett S

AU  - Ireson J

AU  - Hills A

AU  - Tidy JA

AU  - Coleman RE

AU  - Hancock BW

AU  - Winter MC

ED  - 

DO  - DOI: 10.1002/ijc.33403

PB  - Wiley

Y2  - 2025/10/10

ER  -